GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3601 - 3625 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 3 4 mild
G47362BJ
1125
IgA Patient 3 4 mild
G25559RS
1127
IgA Patient 2 24 mild
G22768VO
1132
IgG Patient 2 24 mild
G41200QS
1135
IgA Patient 3 11 mild
G25559RS
1141
IgA Patient 3 11 mild
G42666HT
1146
IgA Patient 3 4 mild
G71142DF
1152
IgG Patient 2 24 mild
G27689OB
1153
IgM Patient 2 3 mild
G00057MO
1155
IgM Patient 2 3 mild
G42666HT
1156
IgA Patient 2 15 mild
G76355TG
1163
IgM Patient 2 3 mild
G81315DD
1164
IgA Patient 3 11 mild
G80587NA
1164
IgA Patient 2 24 mild
G36544AC
1165
IgA Patient 2 24 mild
G00066MO
1190
IgA Patient 4 12 mild
G14844CX
1193
IgA Patient 3 11 mild
G15407YE
1201
IgG Patient 3 -180 mild
G76615YG
1210
IgG Patient 2 3 mild
G72739GY
1211
IgM Patient 4 12 mild
G96865DJ
1216
IgM Patient 3 -180 mild
G15407YE
1222
IgG Patient 3 -180 mild
G37036SF
1230
IgG Patient 3 11 mild
G37036SF
1232
IgM Patient 3 4 mild
G09482NW
1232
IgM Patient 4 12 mild
G43534QA
1234

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024